207 related articles for article (PubMed ID: 2138364)
1. The effect of dermatan sulfate on in vitro human plasma coagulation, platelet aggregation and beta TG/PF4 release.
Cofrancesco E; Colombi M; Gianese F; Cortellaro M
Thromb Res; 1990 Feb; 57(3):405-14. PubMed ID: 2138364
[TBL] [Abstract][Full Text] [Related]
2. Selective PF4 release in vitro induced by heparin and related glycosaminoglycans (GAGs)--correlation with beta-TG release and platelet aggregation.
Cofrancesco E; Colombi M; Cristoforetti G; Pogliani EM
Thromb Haemost; 1984 Feb; 51(1):105-7. PubMed ID: 6202020
[TBL] [Abstract][Full Text] [Related]
3. Effects on platelets and on the clotting system of four glycosaminoglycans extracted from hog mucosa and one extracted from aortic intima of the calf.
Cella G; Scattolo N; Luzzatto G; Stevanato F; Vio C; Girolami A
J Med; 1986; 17(5-6):331-46. PubMed ID: 2953835
[TBL] [Abstract][Full Text] [Related]
4. Effect of oversulfated dermatan sulfate derivatives on platelet aggregation.
Maaroufi RM; Giordano P; Triadou P; Tapon-Bretaudière J; Dautzenberg MD; Fischer AM
Thromb Res; 2007; 120(4):615-21. PubMed ID: 17222891
[TBL] [Abstract][Full Text] [Related]
5. Normal and low molecular weight heparins: interaction with human platelets.
Fabris F; Fussi F; Casonato A; Visentin L; Randi M; Smith MR; Girolami A
Eur J Clin Invest; 1983 Apr; 13(2):135-9. PubMed ID: 6223824
[TBL] [Abstract][Full Text] [Related]
6. Anticoagulant effects of a low molecular weight heparinoid (Org 10172) in human volunteers and haemodialysis patients.
ten Cate H; Henny CP; ten Cate JW; Büller HR; Mooy MC; Surachno S; Wilmink JM
Thromb Res; 1985 Jul; 39(2):211-22. PubMed ID: 3161213
[TBL] [Abstract][Full Text] [Related]
7. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate.
Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA
Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356
[TBL] [Abstract][Full Text] [Related]
8. Effects of glycosaminoglycans and protamine chloridrate on platelet aggregation induced by collagen and thrombin.
Luzzatto G; Paolini R; Stevanato F; Simioni P; Cella G
Angiology; 1989 Mar; 40(3):170-4. PubMed ID: 2916768
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of coagulation and thrombin-induced platelet activities by a synthetic dodecapeptide modeled on the carboxy-terminus of hirudin.
Jakubowski JA; Maraganore JM
Blood; 1990 Jan; 75(2):399-406. PubMed ID: 2294999
[TBL] [Abstract][Full Text] [Related]
10. Platelet aggregation in humans and nonhuman primates: relevance to xenotransplantation.
Iwase H; Ekser B; Zhou H; Dons EM; Cooper DK; Ezzelarab MB
Xenotransplantation; 2012; 19(4):233-43. PubMed ID: 22909136
[TBL] [Abstract][Full Text] [Related]
11. The haemorrhagic and antithrombotic effects of dermatan sulphate.
Fernandez F; Van Ryn J; Ofosu FA; Hirsh J; Buchanan MR
Br J Haematol; 1986 Oct; 64(2):309-17. PubMed ID: 3778825
[TBL] [Abstract][Full Text] [Related]
12. The anticoagulant effect of heparan sulfate and dermatan sulfate.
Teien AN; Abildgaard U; Höök M
Thromb Res; 1976 Jun; 8(6):859-67. PubMed ID: 134464
[No Abstract] [Full Text] [Related]
13. Characterization of a novel dermatan sulfate with high antithrombin activity from ray skin (Raja radula).
Ben Mansour M; Dhahri M; Bertholon I; Ollivier V; Bataille I; Ajzenberg N; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Thromb Res; 2009 Apr; 123(6):887-94. PubMed ID: 19019412
[TBL] [Abstract][Full Text] [Related]
14. Effect of heparin and heparinoids on platelet aggregation.
Cepelák V; Roubal Z; Zemanová I; Opatrný K
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):750-60. PubMed ID: 6083950
[TBL] [Abstract][Full Text] [Related]
15. Influence of proteoglycans (PG) and glycosaminoglycans (GAG) on ADP-, collagen- and thrombin-induced platelet aggregation.
Klein K; Sinzinger H; Silberbauer K; Stachelberger H; Leithner C
Artery; 1980; 8(5):410-5. PubMed ID: 6783013
[TBL] [Abstract][Full Text] [Related]
16. Effects of pressure excursions on human platelets. In vitro studies on betathromboglobulin (beta-TG) and platelet factor 4 (PF4) release and on platelet sensitivity to ADP-aggregation.
Torsellini A; Becucci A; Citi S; Cozzolino F; Guidi G; Lombardi V; Vercelli D; Veloci M
Haematologica; 1982; 67(6):860-6. PubMed ID: 6186580
[No Abstract] [Full Text] [Related]
17. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
Buchanan MR; Brister SJ
Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate.
Sié P; Fernandez F; Caranobe C; Gabaig AM; Boneu B
Thromb Res; 1984 Jul; 35(2):231-6. PubMed ID: 6206589
[No Abstract] [Full Text] [Related]
20. Increased releasability of platelet products and reduced heparin-induced platelet factor 4 release from endothelial cells in bronchial asthma.
Yasuba H; Chihara J; Kino T; Satake N; Oshima S
J Lipid Mediat; 1991; 4(1):5-21. PubMed ID: 1832572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
